Submission Details
| 510(k) Number | K242981 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 26, 2024 |
| Decision Date | June 20, 2025 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K242981 is an FDA 510(k) clearance for the Atellica IM Thyroglobulin (Tg), a System, Test, Thyroglobulin (Class II — Special Controls, product code MSW), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on June 20, 2025, 267 days after receiving the submission on September 26, 2024. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.
| 510(k) Number | K242981 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 26, 2024 |
| Decision Date | June 20, 2025 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | MSW — System, Test, Thyroglobulin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6010 |